Skip to content

First Event of Infection by HIV-1 of Uterine Vaginal Tissue

Inhibition by the Antibody, First Event of Infection by HIV-1 of Uterine Vaginal Tissue

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02481622
Enrollment
600
Registered
2015-06-25
Start date
2015-11-30
Completion date
2019-11-30
Last updated
2017-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infection of the Uterine Vaginal Tissues

Keywords

HIV infection, vaginal tissues, uterine tissues

Brief summary

This non-interventional study aims to characterize the cells infected with HIV over time in different types of vagino-uterine tissue.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Patients whose age ≤50 years and ≥18 years * Patients for which surgery like laparoscopy or hysterectomy is necessary as part of a benign pathology.

Exclusion criteria

* Patients under 18 years

Design outcomes

Primary

MeasureTime frame
identification of the first HIV-infected cells by a histological analysisafter surgery, up to 3 weks

Countries

France

Contacts

Primary ContactJeanine OHL, MD
jeanine.ohl@chru-strasbourg.fr33 3 3 88 11 67 68
Backup ContactChristiane MOOG, PhD
c.moog@unistra.fr33 3 68 85 37 42

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026